Skip to main content

Medicare D and Costly Biologics

25% of Medicare beneficiaries with rheumatoid arthritis use high-cost biologics.  Yazdany and coworkers have analyzed a national cohort of beneficiaries and compared Medicare part D plans. Nearly all Part D plans cover at least 1 biologic DMARD, but the vast majority require cost sharing that is sufficiently high to risk significant financial burden to patients.  Most patients incurred out-of-pocket costs of $2,712–$2,774 before reaching the donut hole. 

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

Disclosures
The author has no conflicts of interest to disclose related to this subject